The association of metabolite concentrations in both plasma and CSF of AD patients with CSF biomarkers (amyloidβ(Aβ)1–42, tau and pTau-181) was evaluated using single and multiple regression modeling (age and gender-corrected, Fig. 5 and Additional file 1: Table S7). The gene discussed is MAPT; the disease is Alzheimer disease.